Sleep Tech Startup Tatch Raises $4.25 Million in Seed Funding

Tatch, a New York startup that builds a flexible, lightweight patch that collects user’s data to diagnose sleep disorders, including sleep apnea, closed a $4.25 million seed funding round led by Spark Capital, with participation from Abstract Ventures and Correlation Ventures.

The startup has raised $5.6 million to date, according to TechCrunch.

With the new funds, the startup plans to scale up its engineering and business teams, doubling the team overall by year’s end.

How it works

Users attach the wearable patch to their torso and wear it through the night. The sensor measures a variety of signals, including breathing airflow, respiratory effort, oxygen levels, and body position to gain a clear picture of how your body is operating during a bad night of sleep. After a few such nights of gathering data, the user will be connected with a specialist who can help interpret the data, diagnose problems, and offer users some following helpful steps.

According to the company, its sensor can diagnose disorders like sleep apnea, restless leg syndrome, insomnia, and some respiratory illnesses. Tatch plans to build around sleep health and ensure that users who get a diagnosis are not left searching endlessly for help with their disorder. Further, the startup will be able to connect users with treatment or facilitate a sleep specialist who can talk them through improving their sleep.

Tatch is not available for sale quite yet, as the company is targeting a market rollout in early 2021. The company says they are in initial conversations with the FDA to receive clearance for the device. The company is gearing up for a pilot program that they are commencing in the next few months.

“This is not a sleep tracker that you need to decipher,” said Amir Reuveny, CEO of Tatch. “We are targeting users at the next step, where you know that something is wrong, and now you want to understand what’s going on.”

Early this year, Element Science, a provider of patch-based wearable cardioverter defibrillator that monitors a patient’s heart, raised $145.6 million in Series C financing. Deerfield Healthcare and Qiming Venture Partners USA led the funding round with participation from Cormorant Asset Management, Invus Opportunities, Third Rock Ventures, and GV (formerly Google Ventures). According to Mercom Q1 report, digital health sensor companies raised $286 million.

Image Credit: Tatch